May 10th, 2013: The Centre for Drug Research and Development (CDRD), Canada’s fully-integrated national drug development and commercialization centre, headquartered in Vancouver British Columbia, is pleased to extend its cross-Canada network of affiliated academic institutions via recent partnerships with Quebec’s Université de Sherbrooke and Université Laval.
Through these affiliations, Sherbrooke and Laval investigators now have access to CDRD’s expertise and state-of-the-art infrastructure to assist them in overcoming scientific and project management challenges, and developing their cutting-edge discoveries into new therapeutics for the treatment of human disease.
The partnerships build on CDRD’s existing affiliation with Montreal’s McGill University, entered into in 2011, and follow on the heels of MERCK’s announcement last month at the International BIO Conference in Chicago that it will provide $2 million to support British Columbia–Quebec corridor projects between CDRD and the Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR), a fellow Centre of Excellence for Commercialization and Research (CECR) created in 2008 to accelerate the process of drug discovery at the Université de Montréal, Institute for Research in Immunology and Cancer (IRIC) and at other University research units.
CDRD President and CEO, Karimah Es Sabar commented, “As a national drug development and commercialization centre, CDRD appreciates the critical importance of building partnerships such as this that bring together complementary resources and expertise from across the country. Our Quebec-based partnerships represent opportunities to further leverage CDRD’s drug development platform to help develop the most commercially-promising discoveries, and break down provincial borders to maintain Canada’s competitive edge on the international scene.”
Looking to expand upon the several projects already underway with researchers at McGill and Laval, members of CDRD’s Project Search and Evaluation team will be presenting and meeting with investigators at both the Université de Sherbrooke and Université Laval next week. Presentation details are as follows:
“Le centre de recherche et de développement de medicaments: CDRD. Aperçu général et avantages pour les chercheurs universitaires”
Université de Sherbrooke:
Institute of Pharmacology of Sherbrooke (Room IPS Z5-3001)
Tuesday, May 14th, 9:30 am
The Quebec International Event
2705, boul. Laurier Québec (CRCHUQ au long Fisher Auditorium)
Thursday, May 16th, 4:00pm
Any investigator interested in exploring collaboration opportunities or learning more about CDRD are welcome to attend, and/or contact:
Dr. John Coleman
Head, Project Search and Evaluation
Dr. Ryan Dercho
Associate Scientist, Project Search and Evaluation
– 30 –
CDRD is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Its mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector — thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).
For additional information, please contact: